Legal & General Group Plc acquired a new position in shares of Envista Holdings Corporation (NYSE:NVST – Free Report) in the second quarter, Holdings Channel reports. The institutional investor acquired 227,212 shares of the company’s stock, valued at approximately $5,987,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Millennium Management LLC raised its stake in Envista by 1,442.7% during the fourth quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock worth $52,552,000 after buying an additional 2,263,712 shares during the last quarter. Holocene Advisors LP bought a new stake in Envista in the second quarter worth approximately $43,936,000. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Envista by 341.5% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,858,293 shares of the company’s stock worth $72,515,000 after buying an additional 2,210,847 shares in the last quarter. Norges Bank acquired a new stake in shares of Envista during the 4th quarter worth approximately $45,113,000. Finally, Alliancebernstein L.P. boosted its stake in Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after acquiring an additional 1,547,656 shares in the last quarter.
Analyst Upgrades and Downgrades
A number of equities analysts have recently issued reports on NVST shares. JPMorgan Chase & Co. raised shares of Envista from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $29.00 to $32.00 in a research report on Thursday. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 22nd. Deutsche Bank Aktiengesellschaft set a $32.00 price objective on shares of Envista in a report on Thursday. Robert W. Baird set a $34.00 price target on shares of Envista in a research report on Thursday, August 6th. Finally, Barclays decreased their price objective on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a report on Thursday, June 11th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $29.71.
Envista Stock Performance
Shares of NVST opened at $27.53 on Friday. The stock has a 50 day moving average of $27.22 and a 200 day moving average of $26.29. The company has a market capitalization of $4.42 billion, a price-to-earnings ratio of 47.47, a PEG ratio of 1.30 and a beta of 0.86. Envista Holdings Corporation has a 12 month low of $18.77 and a 12 month high of $30.42. The company has a current ratio of 2.43, a quick ratio of 2.07 and a debt-to-equity ratio of 0.47.
Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.34 by $0.07. The firm had revenue of $730.50 million during the quarter, compared to the consensus estimate of $716.11 million. Envista had a return on equity of 7.88% and a net margin of 3.33%.The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. As a group, sell-side analysts forecast that Envista Holdings Corporation will post 1.53 earnings per share for the current year.
Insider Activity at Envista
In related news, SVP Mischa Reis sold 8,000 shares of Envista stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $27.50, for a total value of $220,000.00. Following the sale, the senior vice president owned 27,321 shares of the company’s stock, valued at approximately $751,327.50. The trade was a 22.65% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.99% of the company’s stock.
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Read More
- Five stocks we like better than Envista
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
